Klinikum Bremerhaven-Reinkenheide

Patient preferences of German and Swiss melanoma patients with regard to life-threatening side effects in the context of adjuvant immunotherapy - a qualitative GerMelaTox-A substudy (2022) Peters W, Maul LV, Huning S, Hassel JC, Heinzerling L, Loquai C, Gutzmer R, et al. Conference contribution Genetic characterization of advanced conjunctival melanoma and response to systemic treatment (2022) Lodde GC, Jansen P, Möller I, Sucker A, Hassel JC, Forschner A, Eckardt J, et al. Journal article Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis (2021) Zaremba A, Kramer R, De Temple V, Bertram S, Salzmann M, Gesierich A, Reinhardt L, et al. Journal article Melanoma in Pregnancy: CLAUDIUS - a retrospective, multicenter Study to evaluate the Risk of transplacental Transmission to the unborn Child (2021) Gaiser MR, Mueller V, Erdmann M, Buehler B, Dugas-Breit S, Schatton K, Reinhardt L, et al. Conference contribution Hematological immune related adverse events after treatment with immune checkpoint inhibitors (2021) Kramer R, Zaremba A, Moreira A, Ugurel S, Johnson DB, Hassel JC, Salzmann M, et al. Journal article Adjuvant melanoma treatment: real-world data from the DACH region (2021) Schumann K, Mangana J, Dummer R, Sindrilaru M, Reinhardt L, Meier F, Gutzmer R, et al. Conference contribution Management of cutaneous squamous cell carcinoma Vorgehen bei kutanem Plattenepithelkarzinom (2021) Leiter U, Gutzmer R, Alter M, Ulrich C, Meiwes A, Heppt M, Steeb T, et al. Journal article, Review article Agranulocytosis with Immune Checkpoint-Blockade - a retrospective, multicenter Evaluation (2020) Zaremba A, Martaki A, Salzmann M, Baroudjian B, Sachse MM, Gesierich A, Reinhardt L, et al. Conference contribution Kutanes Plattenepithelkarzinom (2020) Leiter U, Gutzmer R, Alter M, Ulrich C, Meiwes A, Heppt M, Steeb T, et al. Journal article, Review article The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial (2017) Jaeger BAS, Neugebauer J, Andergassen U, Melcher C, Schochter F, Mouarrawy D, Ziemendorff G, et al. Journal article